Sumatriptan
Product Images NDC 61919-300

4 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 61919-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure01)

Image Description (Figure01)
A line graph titled 'Estimated Probability of Achieving Initial Headache Response Within 4 Hours of Treatment in Pooled Trials 1, 2, and 3.' The x-axis shows time in minutes from the initial dose (0 to 240 minutes), and the y-axis shows the estimated probability of response from 0% to 100%. Four lines represent different groups: placebo, 25 mg, 50 mg, and 100 mg doses, each showing increasing probability over time, with higher doses generally having higher response probabilities.*
FDA Label Image

Image Description (Figure02)

Image Description (Figure02)
A line graph titled 'The Estimated Probability of Patients Taking a Second Dose of Sumatriptan Tablets or Other Medication to Treat Migraine Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Trials 1, 2, and 3.' The x-axis represents time in hours from the initial dose (0 to 25 hours), and the y-axis represents the estimated probability of medication rescue (0% to 100%). Four lines are plotted for placebo, 25 mg, 50 mg, and 100 mg doses, showing increasing probabilities over time with placebo having the highest rescue probability and 100 mg the lowest.*
FDA Label Image

Image Description (Module1)

Image Description (Module1)
Chemical structure of sumatriptan, showing its indole core with attached side chains including a sulfonamide group and a carboxylic acid containing side chain, consistent with the active ingredient sumatriptan in the product SUMATRIPTAN by DIRECT RX (NDC 61919-300).*
FDA Label Image

Image Description (Label1)

Image Description (Label1)
SUMATRIPTAN 100 mg tablet blister card label with 9 tablets, labeled as generic for IMITREX. The label states each tablet contains sumatriptan succinate USP equivalent to 100 mg sumatriptan. The product is packaged and distributed by DIRECT RX, Alpharetta, GA. It includes lot and expiration date information and instructions to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.